|
WO2021056018A1
|
|
Assembly process for an electronic soft contact lens designed to inhibit progression of myopia
|
|
US10959613B1
|
|
Scan pattern and signal processing for optical coherence tomography
|
|
WO2021022193A1
|
|
Device for projecting images on the retina
|
|
WO2020069330A2
|
|
Inhibitors of vap-1
|
|
CA3114166A1
|
|
Inhibitors of vap-1
|
|
AU2019314262A1
|
|
Optical designs of electronic contact lens to decrease myopia progression
|
|
WO2020014074A1
|
|
Device to prevent retinal hypoxia
|
|
CA3103899A1
|
|
Miniaturized mobile, low cost optical coherence tomography system for home based ophthalmic applications
|
|
US2021069524A1
|
|
Method and apparatus for treating refractive error of the eye
|
|
CN110461213A
|
|
Small-sized movable low-cost optical coherence tomography system based on family's ophthalmic applications
|
|
AU2016202474A1
|
|
Alkoxy compounds for disease treatment
|
|
AU2016201178A1
|
|
Styrenyl derivative compounds for treating ophthalmic diseases and disorders
|
|
AU2015275312A1
|
|
Alkoxy compounds for disease treatment
|
|
WO2015164419A1
|
|
Pupillometric assessment of retinal pharmacodynamics and responses therefrom
|
|
JP2015127294A
|
|
Machinable zirconia and method for producing the same
|
|
US2014275043A1
|
|
Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders
|
|
AU2013234376A1
|
|
Compounds for treating ophthalmic diseases and disorders
|
|
AU2013206281A1
|
|
Sulphur-linked compounds for treating ophthalmic diseases and disorders
|
|
AU2013205722A1
|
|
Amine derivative compounds for treating ophthalmic diseases and disorders
|
|
TW201406707A
|
|
Methods for the treatment of diabetic retinopathy and other ophthalmic diseases
|
